secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001104659-25-097506
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Esperion posts updated corporate presentation; no specific details provided
---------------------------------------------------------------------------

- Company filed 8-K noting October 2025 corporate presentation posted to investor page.
- Exhibit 99.1 is the corporate presentation, but its content was not disclosed in this filing.
- No financial or strategic updates are available from the filing text or exhibit excerpt.
- Investors should review the presentation at esperion.com/investors-media for material information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000110465925097506/0001104659-25-097506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000110465925097506/tm2527818d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-097506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer